List of Tables
Table 1. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Covered in This Study
Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Manufacturers (2016-2021)
Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non Corticosteroid Anti-inflammatory Eyedrops Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Manufacturing Sites and Area Served
Table 11. Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Product Type
Table 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Corticosteroid Anti-inflammatory Eyedrops as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2016-2021) & (K Units)
Table 16. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2016-2021)
Table 17. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2016-2021) & (K Units)
Table 19. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2016-2021)
Table 20. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2016-2021)
Table 22. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2016-2021) & (K Units)
Table 23. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2016-2021)
Table 24. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2016-2021)
Table 32. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2016-2021)
Table 38. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2016-2021)
Table 39. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2016-2021)
Table 40. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Type (2016-2021)
Table 42. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Type (2016-2021)
Table 43. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2016-2021)
Table 44. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2016-2021)
Table 45. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Application (2016-2021)
Table 47. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Application (2016-2021)
Table 48. Novartis AG Corporation Information
Table 49. Novartis AG Description and Business Overview
Table 50. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 52. Novartis AG Recent Developments/Updates
Table 53. Allergan, Inc. Corporation Information
Table 54. Allergan, Inc. Description and Business Overview
Table 55. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 57. Allergan, Inc. Recent Developments/Updates
Table 58. Meda Pharmaceuticals Inc Corporation Information
Table 59. Meda Pharmaceuticals Inc Description and Business Overview
Table 60. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 62. Meda Pharmaceuticals Inc Recent Developments/Updates
Table 63. Bausch & Lomb Inc Corporation Information
Table 64. Bausch & Lomb Inc Description and Business Overview
Table 65. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 67. Bausch & Lomb Inc Recent Developments/Updates
Table 68. Cigna Corporation Information
Table 69. Cigna Description and Business Overview
Table 70. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 72. Cigna Recent Developments/Updates
Table 73. Similasan Corporation Corporation Information
Table 74. Similasan Corporation Description and Business Overview
Table 75. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 77. Similasan Corporation Recent Developments/Updates
Table 78. Visine Corporation Information
Table 79. Visine Description and Business Overview
Table 80. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 82. Visine Recent Developments/Updates
Table 83. Alcon Corporation Information
Table 84. Alcon Description and Business Overview
Table 85. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 87. Alcon Recent Developments/Updates
Table 88. Viva Opti-Free Corporation Information
Table 89. Viva Opti-Free Description and Business Overview
Table 90. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 92. Viva Opti-Free Recent Developments/Updates
Table 93. Bausch & Lomb Corporation Information
Table 94. Bausch & Lomb Description and Business Overview
Table 95. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 97. Bausch & Lomb Recent Developments/Updates
Table 98. Systane Corporation Information
Table 99. Systane Description and Business Overview
Table 100. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 102. Systane Recent Developments/Updates
Table 103. Rite Aid Corporation Information
Table 104. Rite Aid Description and Business Overview
Table 105. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 107. Rite Aid Recent Developments/Updates
Table 108. Walgreens Corporation Information
Table 109. Walgreens Description and Business Overview
Table 110. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 112. Walgreens Recent Developments/Updates
Table 113. Staples Corporation Information
Table 114. Staples Description and Business Overview
Table 115. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 117. Staples Recent Developments/Updates
Table 118. Clear eyes Corporation Information
Table 119. Clear eyes Description and Business Overview
Table 120. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 122. Clear eyes Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List
Table 126. Non Corticosteroid Anti-inflammatory Eyedrops Customers List
Table 127. Non Corticosteroid Anti-inflammatory Eyedrops Market Trends
Table 128. Non Corticosteroid Anti-inflammatory Eyedrops Growth Drivers
Table 129. Non Corticosteroid Anti-inflammatory Eyedrops Market Restraints
Table 130. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Type in 2020 & 2027
Figure 3. Ocufen Product Picture
Figure 4. Mugabe Product Picture
Figure 5. Diclofenac Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Application in 2020 & 2027
Figure 8. Adult
Figure 9. Children
Figure 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size 2016-2027 (US$ Million)
Figure 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales 2016-2027 (K Units)
Figure 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Manufacturers in 2020
Figure 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Non Corticosteroid Anti-inflammatory Eyedrops Players: Market Share by Revenue in 2020
Figure 17. Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2016-2021)
Figure 19. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region in 2020
Figure 20. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2016-2021)
Figure 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region in 2020
Figure 22. U.S. Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Type (2016-2021)
Figure 47. Sales Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application (2016-2021)
Figure 48. Sales Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application in 2020
Figure 49. Revenue Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application (2016-2021)
Figure 50. Revenue Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application in 2020
Figure 51. Manufacturing Cost Structure of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 52. Manufacturing Process Analysis of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 53. Non Corticosteroid Anti-inflammatory Eyedrops Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

LIST OF FIGURE